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Cervical ectopic pregnancies are rare, but their inci-
dence is increased in patients with previous cesarean
deliveries, previous therapeutic abortions, Ascherman
syndrome or in vitro fertilization [1]. Treatment is diffi-
cult, because dilatation and curettage of a cervical preg-
nancy frequently results in uncontrollable hemorrhage
and the need for an emergency hysterectomy. Recent
advances in high-resolution ultrasound and color
Doppler have made the diagnosis of early cervical preg-
nancies easier, and have led to the development of sev-
eral conservative approaches that preserve fertility.
Several published reports have described the success-
ful use of chemotherapy, such as methotrexate, in the
management of cervical pregnancy. However, further
intervention may be required following methotrexate
treatment [2]. Here, we describe a case of a viable cer-
vical pregnancy successfully treated with methotrexate
administration and a resectoscopic procedure.
A woman, aged 34 years, gravida 4, para 2, abor-
tus 1, presented at our emergency department with a 
1-day history of lower abdominal pain and vaginal
bleeding. She had previously received two cesarean
sections, and her last menstrual period had occurred 
7 weeks previously. She had visited her local gynecolo-
gist first and was transferred to our hospital because a
viable cervical pregnancy was diagnosed.
Before examination, her vital signs were stable and
her hemoglobin level was 12.8 mg/dL. The urine preg-
nancy test was positive. Pelvic examination revealed a
small amount of bloody discharge protruding from the
cervical os. Transabdominal sonography displayed an
empty uterine cavity and a 20-mm gestational sac lo-
cated in the cervical canal; this showed fetal cardiac
activity. The color Doppler study demonstrated increased
flow in the posterior wall of the cervix (Figure 1). The
initial serum human chorionic gonadotropin (hCG) level
was 14,988 mIU/mL. A diagnosis of cervical ectopic
pregnancy was made.
The patient was admitted and methods of preg-
nancy termination were discussed. She chose medical
treatment by intramuscular injection of 50 mg of meth-
otrexate. The patient’s hematologic and biochemical
parameters remained normal over the following 2 days
after treatment. Her vaginal bleeding decreased to an
unmeasurable level. She was discharged and scheduled
for follow-up 1 week later.
The patient returned to our hospital with vaginal
bleeding 3 days later. A sonographic scan showed an
irregular gestational sac with no fetal heart activity. Color
signals indicating peritrophoblastic flow were absent.
Her hemoglobin level was 11.1 mg/dL, and her serum
hCG concentration was 9,840 mIU/mL. She was read-
mitted. There was no active bleeding over the next 
4 days, and the level of serum hCG decreased to
2,611 mIU/mL. We advised the patient that surgical
intervention should be considered if the gestational sac
was not expulsed or if the size of the gestational mass
remained unchanged over the next week. At 2 weeks
after the first methotrexate therapy, the serum hCG level
had continued to gradually decline, but intermittent vagi-
nal bleeding was still present and the gestational mass in
the cervical canal, which was unchanged in size, annoyed
the patient. In view of the above problems, we arranged
for hysteroscopic resection of the ectopic mass.
In the operating room, before dilatation of the cervix,
sutures were placed at the 3 o’clock and 9 o’clock
positions on the lateral sides of the cervix. A solution
of 10 U of vasopressin diluted in 20 mL of saline was
then injected intracervically at the 3 o’clock, 6 o’clock,
9 o’clock and 12 o’clock positions. The endocervical
canal was dilated to 12 mm, and some tissue slid down.
The hysteroscope was inserted into the cervix, and a
small amount of residual tissue attached to the posterior
wall of the cervix was identified and completely resected
under direct visualization (Figure 2). We coagulated an
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Figure 1. (A) The endometrial (EM) cavity is empty and a gestational sac with positive fetal heart beat is located in the endo-
cervical canal. (B) Doppler sonography detects the vascular flow in the gestational sac in the posterior wall of cervix.
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Figure 2. (A) The hysteroscopic finding after dilatation of the cervical canal is a small amount of gestational tissue on the
posterior endocervical wall. (B) The residual gestational tissue is removed. (C) Some tissue adheres to the cervix. (D) The
endocervix after electrocauterization.
area of active bleeding using a loop electrode. The esti-
mated blood loss during the operation was less than
10 mL. The procedure took approximately 30 minutes.
The postoperative course was uneventful, and there was
no more vaginal bleeding. The patient’s serum hCG
concentration was normal 14 days after the hysteros-
copic resection (Figure 3). Her menstruation returned
to normal 4 weeks after surgery.
The estimated incidence of a cervical pregnancy
has been reported to range from 1/1,000 to 1/18,000
pregnancies [3]. Cervical pregnancy has traditionally
been treated by hysterectomy because of profuse hem-
orrhage associated with curettage, due to presumed
incomplete abortion. Alternative therapies that avoid
the risk of uncontrollable hemorrhage and preserve fer-
tility in women with cervical pregnancies are needed.
These include cervical cerclage, cervical amputation,
hypogastric artery ligation, cervical Foley tamponade,
and uterine artery embolization [4]. In recent years,
improved access to high-resolution ultrasound and rapid
assays for serum hCG have made conservative treatments
more feasible.
The application of the anti-metabolic drug, metho-
trexate, in the medical management of early ectopic
pregnancy has been widely described, because it is
both convenient to use and results in a good prognosis
[2]. Several reports and case series since 1990 have
cited success rates of more than 80% in selected cases
using methotrexate therapy [1,4,5]. Nevertheless, cervical
pregnancies presenting with serum hCG ≥ 10,000 mIU/
mL, gestational age ≥ 9 weeks, the presence of fetal
heart beats or a fetal crown-rump length > 10 mm
have been shown to be associated with a higher rate of
primary methotrexate failure and may need additional
interventions [6].
Methotrexate can be administered by two different
routes. The systemic route has advantages over local
injection in terms of its simplicity, and is applicable in
more patients [7]. The efficacies of high-dose and low-
dose regimens are similar [6,8]. The main benefits asso-
ciated with intra-amniotic injection are: (1) greater
effectiveness, (2) a shorter treatment period, and (3)
reduced dosage and toxicity compared with intramus-
cular administration [9]. However, this approach is
technically more difficult than the parenteral route.
There is a strong possibility of active bleeding follow-
ing local injection, caused by rupture of the intra-
amniotic membrane [10].
In this case, we initially opted for systemic (intra-
muscular) methotrexate administration to treat a cer-
vical pregnancy of approximately 7 weeks’ gestation.
Although the patient’s serum hCG levels were consis-
tent with a satisfactory response to methotrexate and
no fetal cardiac activity was detected, a sonographic
scan revealed a persistent cervical mass. Common prob-
lems associated with methotrexate therapy, both local
and systemic, include the inability to predict the occur-
rence of massive bleeding, the possibility of a slow res-
olution of the trophoblasts, and a time-consuming
follow-up. Several studies have indicated that a per-
sistent cervical mass should not be regarded as a treat-
ment failure. In this case, the presence of diminished
Doppler signs of peritrophoblastic flow and a decline
in the serum hCG level reflected a therapeutic response
[11,12]. Nonetheless, the size of the cervical pregnancy
continued to increase after methotrexate treatment,
possibly as a result of an inflammatory response, tis-
sue swelling or internal hemorrhaging within the gesta-
tional sac. Furthermore, the pregnancy product may
not be completed expulsed. Despite a normal serum
hCG concentration and resumption of the menstrual
cycle, the mean period from initial methotrexate treat-
ment until sonographic non-visualization of the cervi-
cal mass has been reported to be as long as 72 days
[13]. Cervical pregnancy tissue retained in the cervix
may serve as a culture medium for further infection
[14]. Intractable bleeding is likely to occur owing to
tissue sloughing and necrosis from the atonic cervix
[6,11]. Surgical hemostasis and removal of the gesta-
tional mass should be considered to prevent these
possibilities.
Operative hysteroscopy is superior to curettage,
because it provides direct visualization of the ectopic
location and its vascularity, which is helpful in achiev-
ing complete eradication and the accurate cauteriza-
tion of any bleeding [15]. However, even minimal surgical
methods, such as simple curettage or hysteroscopy,
still carry a risk of uncontrolled bleeding, and the patient
should be aware of the possible need for an emergency
hysterectomy. Hysteroscopy also allows confirmation
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Figure 3. Changes in serum human chorionic gonadotropin
(hCG) levels during and after methotrexate (MTX) treatment.
of the diagnosis of cervical pregnancy [15,16]. We did
not collect sufficient specimens in this case, and the
pathology report described the presence of only a very
small amount of necrotic tissue and endocervical tis-
sue; but based on the sonographic and hysteroscopic
findings, the diagnosis of cervical pregnancy was beyond
question.
Some authors are hesitant to attempt removal of
an ectopic mass after systemic methotrexate treatment,
while others routinely attempt such a removal. Roussis
et al demonstrated hysteroscopic resection of a cervi-
cal pregnancy for the first time in 1992 [17]. They per-
formed resectoscopic surgery to remove the cervical
mass at 40 days after systemic methotrexate adminis-
tration. Before surgery, the serum hCG level was unde-
tectable and decreased blood flow velocities were noted
in the area of the gestational sac. Another patient with
a 7-week viable cervical pregnancy underwent two
courses of intramuscular methotrexate injections [18].
After the serum hCG level had declined and a dead
embryo had been observed, operative hysteroscopy
with ablation of the bleeding was carried out. These
authors indicated that methotrexate therapy was able
to induce effective regression of the viable cervical preg-
nancy, resulting in decreased blood loss during surgical
intervention. Thus, complete resection via hysteroscopy
was a safe procedure, and satisfactory hemostasis was
easily achieved.
In order to avoid the side effects of methotrexate
therapy, an alternative “one-stage” treatment using oper-
ative hysteroscopy has been reported. Ash and Farrell
reported a 6-week viable cervical pregnancy that was
successfully removed by hysteroscopic resection after
ligation of the cervical branch of the uterine artery at
the junction between the cervix and the vagina [15].
Jozwiak et al [19] described a woman with a 6-week
cervical heterotopic pregnancy, who was treated by
hysteroscopy alone, in order to preserve an intrauter-
ine fetus. The woman delivered a healthy term baby.
However, the safety of a simple hysteroscopic resec-
tion without preoperative blockage of the blood flow
around the cervix remains unclear. Hysteroscopy may
not be appropriate for more advanced gestations with
better blood supplies. Kung et al reported six women
with cervical pregnancies ranging from 6–9 weeks,
who received resectoscopy immediately after laparo-
scopic uterine artery ligation [16]. The mean operative
time was 119 minutes. Vilos et al described a procedure
where hysteroscopic evacuation with transfemoral uter-
ine artery embolization was successful for the treat-
ment of a 10-week viable cervical pregnancy [20]. This
patient initially presented with acute heavy bleeding.
She had no active bleeding after embolization, and
serum hCG levels also decreased and fetal cardiac activ-
ity ceased. The authors then proceeded to hysteroscopic
evacuation.
In our opinion, the laparoscopic procedure is too
invasive, and angiographic embolization requires radio-
logic facilities with specialized instrumentation and exper-
tise. Uterine artery occlusion is often performed to
control massive bleeding in patients wishing to pre-
serve their uterus or in patients with failed methotrex-
ate treatment. However, potential harm to further fertility
and pregnancy outcome has previously been demon-
strated following uterine artery occlusion for the treat-
ment of symptomatic myomas [21]. In addition, the
possibility of rebleeding exists after blockage of the
uterine arteries caused by deep invasion of gestational
tissue into the cervical stroma, which remains alive
after a short period of ischemia [22].
The most efficient treatment for cervical pregnancy
remains uncertain. The incidence of cervical pregnancy
is very low, making the evaluation of conservative
methods by prospective randomized studies difficult.
The choice of treatment is based on the patients’ con-
dition, their requirements, the risk factors, the availabil-
ity of the various therapies, and the clinician’s experience.
We suggest that hysteroscopic resection should be
performed following methotrexate treatment when:
(1) there is a satisfactory decline in the serum hCG
level, (2) the fetus is dead, (3) there is decreased per-
itrophoblastic flow, and (4) there is no active massive
hemorrhage. In conclusion, systemic methotrexate ad-
ministration combined with resectoscopic ablation can
result in safe, successful remission of a cervical preg-
nancy, while maintaining satisfactory hemostasis.
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